• LAST PRICE
    0.0250
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.0150/ 388
  • Ask / Lots
    0.0250/ 133
  • Open / Previous Close
    --- / 0.0250
  • Day Range
    ---
  • 52 Week Range
    Low 0.0150
    High 0.1150
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
CanadaNAV
Navco Pharmaceuticals Inc
1.4M
-8.1x
---
As of 2024-11-13

Company Information

Navco Pharmaceuticals Inc. is a Canada-based company. The Company is engaged in developing and commercializing products to protect against viruses, bacteria, and infectious diseases. It manufactures and researches nanotechnology products and materials using Computerized Nano-meter Algorithms (CNA). The Company's pipeline of applications is tailored to defend against microorganisms such as viruses, bacteria, fungi, and genetic manipulation tools such as clustered regularly interspaced short palindromic repeats (CRISPR). Its target markets include human health and personal skin care, household and institutional products and veterinary health. It offers multiple main product lines, namely, an aerosol spray, hand sanitizer, hand cream, and nano BioGuard-Silver. It also offers sublingual strips (the MunoStrips) infused with immune-boosting compounds to help maintain immune function and help support the body’s metabolism.

Contact Information

Headquarters
Suite 1500, 1055 West Georgia StreetVancouver, BC, Canada V6E 4N7
Phone
604-307-8290
Fax
604-909-2679

Executives

Chief Executive Officer
Geoffrey Lee
Chief Financial Officer
Christopher Cooper
Chief Operating Officer, Director
Marek Jasinski
Corporate Secretary, Director
Thomas Jusdanis
Independent Director
Jatinder Dhaliwal

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.4M
Revenue (TTM)
$0.00
Shares Outstanding
57.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$0.00
Book Value
$0.00
P/E Ratio
-8.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
2.5x
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.